Key Developments: MedAssets Inc (MDAS.OQ)

MDAS.OQ on NASDAQ Stock Exchange Global Select Market

19.05USD
9:55am EST
Price Change (% chg)

$0.19 (+1.01%)
Prev Close
$18.86
Open
$19.20
Day's High
$19.20
Day's Low
$18.98
Volume
13,405
Avg. Vol
185,444
52-wk High
$26.09
52-wk Low
$18.17

Search Stocks

Latest Key Developments (Source: Significant Developments)

Medassets Inc gives FY 2014 guidance in line with analysts' estimates
Wednesday, 26 Feb 2014 04:04pm EST 

Medassets Inc:Expects FY 2014 total net revenue of between $700-$714 million, non-GAAP adjusted EBITDA of between $232-$242 million, GAAP diluted EPS $0.57-$0.67 and diluted non-GAAP adjusted EPS of $1.33-$1.43.FY 2014 revenue of $709 million, EBITDA of $235 million and EPS of $1.40 - Thomson Reuters I/B/E/S.  Full Article

Richmond University Medical Center renews longstanding services relationship with Medassets Inc to improve revenue performance
Thursday, 23 Jan 2014 08:30am EST 

Medassets Inc:Says Richmond University Medical Center (RUMC) is among the latest health providers to select MedAssets Recovery and Collection Solutions in order to sustain practice operational and financial performance.Says under terms of the agreement, RUMC has renewed its longstanding use of MedAssets Extended Business Office Services to support fast and efficient conversion of accounts receivable (A/R) to revenue and cash flow.  Full Article

Medassets Inc renews agreement with Kaiser Permanente
Wednesday, 15 Jan 2014 02:00pm EST 

Medassets Inc:Says it has renewed a multi-year agreement with Kaiser Permanente, the healthcare provider in California, to provide Strategic Sourcing and Spend Analytics solutions.Says under the terms of the agreement, MedAssets will continue to serve as the exclusive group purchasing organization for Kaiser Permanente facilities across the country.  Full Article

Medassets Inc reaffirms FY 2013 guidance- Conference Call
Tuesday, 14 Jan 2014 11:30am EST 

Medassets Inc:Says it reaffirming FY 2013 guidance.Says the company is targeting around 5 pct, plus or minus, on revenue; consolidated EBITDA between about 4 pct and 7 pct; and adjusted EPS between about 12.5 pct to about 16 pct versus prior year.Says for FY 2013, the company anticipating $674 million of revenue with $219 million of adjusted EBITDA.FY 2013 revenue of $675 million , EBITDA of $220 million and EPS of $1.30 - Thomson Reuters I/B/E/S.  Full Article

Medassets Inc Lowers FY 2013 Revenue And EBITDA Guidance; Narrows FY 2013 EPS Guidance
Wednesday, 30 Oct 2013 04:04pm EDT 

Medassets Inc announced for fiscal 2013, it expects total net revenue of between $671.0-$677.0 million, non-GAAP adjusted EBITDA of between $216.0-$222.0 million, GAAP diluted EPS $0.39-$0.43 and diluted non-GAAP adjusted EPS of $1.27-$1.31. According to I/B/E/S Estimates analysts are expecting the Company to report revenue of $680 million, EBITDA of $222 million and EPS of $1.32 for fiscal 2013.  Full Article

Medassets Inc Narrows FY 2013 Revenue Guidance To A Range In Line With Analysts' Estimates; Raises Low End Of Prior FY 2013 Earnings Guidance To A Range In Line With Analysts' Estimates
Wednesday, 31 Jul 2013 04:04pm EDT 

Medassets Inc announced for fiscal 2013, it expects total net revenue of between $673.0-$683.0 million, non-GAAP adjusted EBITDA of between $217.0-$225.0 million, GAAP diluted EPS $0.38-$0.44 and diluted non-GAAP adjusted EPS of $1.26-$1.32. According to I/B/E/S Estimates analysts are expecting the Company to report revenue of $679 million, EBITDA of $219 million and EPS of $1.30 for fiscal 2013.  Full Article

Cerner Corp and Medassets Inc Expand Collaboration, Integrate Technologies to Improve Hospital Operational and Financial Performance
Tuesday, 18 Jun 2013 01:32pm EDT 

Cerner Corp and Medassets Inc announced the expansion of the companies` business relationship. Knowledge components of MedAssets Claims Management solution will be embedded within the Cerner Patient Accounting solution to give Cerner clients significantly enhanced claims processing workflow capabilities, operational efficiencies and optimized payments. The agreement builds upon the two companies` reseller agreement, which enables Cerner to market MedAssets end-to-end portfolio of Web-based revenue cycle solutions. It also reflects a mutual commitment to offer interoperable solutions that care providers to swiftly adopt the latest revenue cycle technologies in support of improving the efficiency and effectiveness of the healthcare industry.  Full Article

Medassets Inc Reaffirms FY 2013 Guidance
Wednesday, 1 May 2013 04:04pm EDT 

Medassets Inc announced that for fiscal 2013, it confirms and expects total net revenue of between $670-$684 million, non-GAAP adjusted EBITDA of between $215-$225 million, GAAP diluted EPS $0.32-$0.42 and diluted non-GAAP adjusted EPS of $1.22-$1.32. According to I/B/E/S Estimates analysts are expecting the Company to report revenue of $680 million, EBITDA of $222 million and EPS of $1.29 for fiscal 2013.  Full Article

Medassets Inc Issues FY 2013 Guidance In Line With Analysts' Estimates
Wednesday, 20 Feb 2013 04:03pm EST 

MedAssets, Inc. announced that for fiscal 2013, it expects total net revenue of between $670-$684 million, non-GAAP adjusted EBITDA of between $215-$225 million, GAAP diluted EPS $0.33-$0.43 and diluted non-GAAP adjusted EPS of $1.22-$1.32. According to I/B/E/S Estimates analysts are expecting the Company to report revenue of $678 million, EBITDA of $223 million and EPS of $1.29 for fiscal 2013.  Full Article

Search Stocks